Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up | Zendy

Emilie van Lingen | Zendy; ME Tushuizen | Zendy; Maurice Steenhuis | Zendy; T. van Deynen | Zendy; Jennifer Martens | Zendy; Diego Morales | Zendy; Andrea E. van der Meulen–de Jong | Zendy; Ilse Molendijk | Zendy; Sander van der Marel | Zendy; J Maljaars | Zendy

Open Access

Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up

Author(s) -

Emilie van Lingen,

ME Tushuizen,

Maurice Steenhuis,

T. van Deynen,

Jennifer Martens,

Diego Morales,

Andrea E. van der Meulen–de Jong,

Ilse Molendijk,

Sander van der Marel,

J Maljaars

Publication year - 2021

Publication title -

international journal of colorectal disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.831

H-Index - 88

eISSN - 1432-1262

pISSN - 0179-1958

DOI - 10.1007/s00384-021-04065-8

Subject(s) - medicine , gastroenterology , transient elastography , steatosis , fibrosis , fatty liver , hepatology , inflammatory bowel disease , liver disease , univariate analysis , disease , liver fibrosis , multivariate analysis

Liver steatosis is a frequently reported condition in patients with inflammatory bowel disease (IBD). Different factors, both metabolic and IBD-associated, are believed to contribute to the pathogenesis. The aim of our study was to calculate the prevalence of liver steatosis and fibrosis in IBD patients and to evaluate which factors influence changes in steatosis and fibrosis during follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research